| Autoimmune liver disease in patients with systemic lupus erythematosus: A retrospective analysis of 147 cases. | |
| | |
MedLine Citation:
|
PMID: 21348808 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Abstract Objective. We aimed to investigate the characteristics of autoimmune liver disease (AILD) developed in patients with systemic lupus erythematosus (SLE), including autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC) and the AIH/PBC overlap syndrome. We also evaluated the accuracy of diagnostic criteria and scoring systems for AILD in SLE. Methods. A retrospective analysis of patients attending the rheumatology and gastroenterology clinics in Ankara, Turkey, between 1999 and 2010. SLE patients with elevated liver enzymes were investigated for liver diseases. Results. A total of 147 SLE patients were identified and 36 of them had liver enzyme abnormalities. AILD was diagnosed in 4.7% of all SLE patients, in 19.4% of those with elevated liver enzymes. Of patients with liver enzyme abnormalities, 72.3% fulfilled the criteria for AIH proposed by the International Autoimmune Hepatitis Group (IAIHG), whereas 66.7% had AIH by using the simplified criteria. Yet, only 13.8% of these patients had liver biopsy findings consistent with AIH. Patients with AILD were treated with conventional therapy including ursodeoxycholic acid, prednisolone, azathioprine or combinations of these. Treatment failure and subsequent advanced liver disease developed in one patient. Conclusions. AILD may occur during the course of SLE. Due to biochemical similarities between AIH and SLE, AIH could be considered very probable by using both IAIHG scoring system and simplified criteria. For definitive diagnosis of AIH, liver biopsy should be performed in all SLE patients with chronic enzyme abnormalities. The response to therapy is favorable in these patients, and early diagnosis is important for preventing advanced liver disease. |
| | |
Authors:
|
Cumali Efe; Tugrul Purnak; Ersan Ozaslan; Zeynep Ozbalkan; Yasar Karaaslan; Emin Altiparmak; Paolo Muratori; Staffan Wahlin |
Related Documents
:
|
19614938 - A retrospective review of calcium hydroxylapatite for correction of volume loss in the ... 3819528 - Evaluation of a continual compliance monitoring program for dapsone in an outpatient ha... 18211658 - Implications of rigid adherence to a protocol of investigation for patients undergoing ... 23169418 - Minocycline-induced hyperpigmentation in multibacillary leprosy. 4006538 - Amiodarone pulmonary toxicity. chest radiography and ct in asymptomatic patients. 7587788 - Localization of an obstructing esophageal lesion. is the patient accurate? |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-2-25 |
Journal Detail:
|
Title: Scandinavian journal of gastroenterology Volume: - ISSN: 1502-7708 ISO Abbreviation: - Publication Date: 2011 Feb |
Date Detail:
|
Created Date: 2011-2-25 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0060105 Medline TA: Scand J Gastroenterol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Internal Medicine, Ankara Numune Research and Education Hospital, Ankara, Turkey. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Medical resource utilisation and healthcare costs in patients with chronic hepatitis C viral infecti...
Next Document: The pentose phosphate pathway is a metabolic redox sensor and regulates transcription during the ant...